Portfolio Holdings Detail for ISIN IE00BYXG2H39

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE

Holdings detail for IGMS

Show aggregate IGMS holdings

News associated with IGMS

Millennium Management LLC Decreases Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS)

Millennium Management LLC trimmed its holdings in shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) by 45.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 83,468 shares of the company’s stock after selling 69,074 shares during the quarter. Millennium Management LLC’s holdings […] - 2025-06-09 04:24:48

IGM Biosciences (NASDAQ:IGMS) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from a sell rating to a hold rating in a report issued on Friday morning. IGM Biosciences Price Performance NASDAQ IGMS opened at $1.28 on Friday. The business has a 50 day simple moving average of $1.22 and a 200 day simple moving […] - 2025-06-02 03:02:48

Geode Capital Management LLC Has $2.50 Million Stock Position in IGM Biosciences, Inc. (NASDAQ:IGMS)

Geode Capital Management LLC raised its position in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) by 3.4% in the 4th quarter, HoldingsChannel reports. The fund owned 409,133 shares of the company’s stock after purchasing an additional 13,334 shares during the period. Geode Capital Management LLC’s holdings in IGM Biosciences were worth $2,501,000 as of its […] - 2025-04-29 04:30:51

IGM Biosciences, Inc. (NASDAQ:IGMS) Short Interest Update

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 928,300 shares, a decline of 19.3% from the February 28th total of 1,150,000 shares. Based on an average daily volume of 448,700 shares, the days-to-cover ratio […] - 2025-03-31 05:00:54

Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) Price Target at $5.50

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has earned a consensus recommendation of “Reduce” from the ten analysts that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and nine have issued a hold rating on the company. The average 1-year target price among brokerages […] - 2025-02-06 04:24:50

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) IGMS holdings

Share Trades of IGMS by Blackrock for IE00BYXG2H39

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-07-11	SELL	-440			1.360*		1.44 Profit of 634 on sale
2025-07-07	BUY	165			1.350*		1.44
2025-07-02	BUY	3,025			1.320*		1.45
2025-06-25	BUY	110			1.210*		1.46
2025-06-11	BUY	110			1.270*		1.48
2025-06-10	BUY	110			1.350*		1.48
2025-06-04	SELL	-55			1.260*		1.49 Profit of 82 on sale
2025-04-23	BUY	55			1.390*		1.59
2025-04-10	SELL	-440			1.060*		1.63 Profit of 719 on sale
2025-04-08	SELL	-55			1.020*		1.65 Profit of 91 on sale
2025-04-07	SELL	-55			1.120*		1.66 Profit of 91 on sale
2025-04-04	SELL	-275			1.130*		1.67 Profit of 459 on sale
2025-04-01	BUY	220			1.150*		1.69
2025-03-31	SELL	-165			1.150*		1.69 Profit of 280 on sale
2025-03-14	SELL	-880			1.235*		1.80 Profit of 1,583 on sale
2025-03-07	SELL	-110			1.320*		1.85 Profit of 204 on sale
2025-03-04	SELL	-55			1.330*		1.89 Profit of 104 on sale
2025-02-25	BUY	110			1.310*		1.97
2025-02-19	SELL	-55			1.520*		2.04 Profit of 112 on sale
2025-02-13	BUY	165			1.370*		2.14
2025-02-12	BUY	55			1.380*		2.16
2025-02-11	BUY	220			1.290*		2.20
2025-01-17	BUY	220			1.770*		3.50
2025-01-16	BUY	220			1.830*		3.74
2025-01-13	SELL	-110			1.775*		5.18 Profit of 569 on sale
2025-01-08	SELL	-220			6.200*		6.21 Profit of 1,366 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IGMS

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy